In the first study to comprehensively evaluate research priorities for patient safety in pediatrics, researchers from Memphis, Tenn.-based St. Jude Children’s Research Hospital and other children’s ...

A blood test using artificial intelligence and DNA sequencing technology can detect bloodstream infections in pediatric leukemia patients several days before symptoms appeared, according to new ...

Clinician-scientists at St. Jude Children's Research Hospital and collaborators have conducted the largest study of infant-type hemispheric glioma (IHG) ever reported, uncovering key factors that ...

Physicians at St. Jude Children's Research Hospital have demonstrated that children with bilateral Wilms tumor, a cancer of the kidneys, can retain normal function in both kidneys by undergoing a ...

St. Jude Medical ($STJ) expects that gains in the neuromodulation market will undergird an improved revenue growth rate over the next few years. Key to that strategy ...

St. Jude Medical Quartet quadripolar lead performed better than bipolar leads of any kind ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc., a global medical device company, today announced ...

The U.S. Food and Drug Administration has given the thumbs up to St. Jude Medical (NYSE:STJ) that allows the Minnesota medical device maker to expand a clinical study of a deep brain stimulation ...

This study builds on the growing body of evidence for managing heart failure using the St. Jude Medical MultiPoint pacing technology for patients not responsive to other therapy options ST. PAUL, Minn ...

(MEMPHIS, TENN.--June 3, 2003) African-American children who have siblings with sickle cell disease (SCD) are more likely to have abnormal, "twisted" arteries in the brain, which may lead to an ...

St. Jude moves forward with treatment for depression. The U.S. Food and Drug Administration has given the thumbs up to St. Jude Medical (NYSE: STJ) that allows the Minnesota medical device maker to ...